DURANTE, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 2.939
AS - Asia 2.328
EU - Europa 1.917
AF - Africa 253
Continente sconosciuto - Info sul continente non disponibili 148
SA - Sud America 116
OC - Oceania 5
Totale 7.706
Nazione #
US - Stati Uniti d'America 2.897
VN - Vietnam 686
CN - Cina 619
SG - Singapore 598
GB - Regno Unito 452
IT - Italia 334
SE - Svezia 301
DE - Germania 258
HK - Hong Kong 125
FR - Francia 111
RU - Federazione Russa 102
IN - India 98
NL - Olanda 79
BR - Brasile 75
IE - Irlanda 72
CI - Costa d'Avorio 62
CH - Svizzera 57
TG - Togo 51
ZA - Sudafrica 50
NG - Nigeria 49
EE - Estonia 34
UA - Ucraina 33
FI - Finlandia 32
JO - Giordania 31
CA - Canada 29
JP - Giappone 29
IR - Iran 28
SC - Seychelles 27
AR - Argentina 19
BD - Bangladesh 19
ID - Indonesia 15
PH - Filippine 13
BG - Bulgaria 11
BE - Belgio 10
IQ - Iraq 10
TH - Thailandia 10
MX - Messico 8
PL - Polonia 8
CO - Colombia 6
KR - Corea 6
PK - Pakistan 6
TR - Turchia 6
UZ - Uzbekistan 6
CL - Cile 5
AU - Australia 4
LB - Libano 4
SA - Arabia Saudita 4
TW - Taiwan 4
AT - Austria 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EC - Ecuador 3
ES - Italia 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AL - Albania 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
SV - El Salvador 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
GT - Guatemala 1
GY - Guiana 1
JM - Giamaica 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
Totale 7.560
Città #
Singapore 416
Southend 406
Ashburn 402
Chandler 249
Fairfield 233
San Jose 147
Ho Chi Minh City 138
Beijing 125
Hong Kong 120
Houston 119
Santa Clara 119
Hanoi 109
Woodbridge 108
Wilmington 105
Seattle 102
Ann Arbor 92
Princeton 91
Dong Ket 84
Dallas 82
Cambridge 74
Dublin 72
Boardman 67
Abidjan 62
New York 57
Bern 56
Bologna 54
Lomé 51
Council Bluffs 48
Nanjing 45
Pavia 45
Lauterbourg 41
Padova 40
Westminster 40
Los Angeles 38
Amman 30
Frankfurt am Main 30
Jinan 29
Abeokuta 27
Helsinki 27
Nanchang 26
Medford 25
Shenyang 23
Berlin 22
Haiphong 22
Tokyo 22
Saint Petersburg 20
São Paulo 19
Munich 18
Buffalo 17
Milan 17
Tianjin 17
Bremen 16
Guangzhou 16
Hebei 16
San Diego 16
Washington 16
Rome 15
Johannesburg 14
Turin 14
Da Nang 13
Kuban 13
Redondo Beach 12
Changsha 11
Falkenstein 11
Florence 11
Hangzhou 11
Sofia 11
Tehran 11
Tongling 11
Toronto 11
Brussels 10
Chengdu 10
Igea Marina 10
Denver 9
Falls Church 9
Shanghai 9
Pune 8
Biên Hòa 7
Calderara Di Reno 7
Jakarta 7
Jiaxing 7
Redwood City 7
Zhengzhou 7
Hải Dương 6
Jacksonville 6
Orem 6
Phoenix 6
Wuhan 6
Brooklyn 5
Bühl 5
Bến Tre 5
Can Tho 5
Haikou 5
Lanzhou 5
Montreal 5
Mülheim 5
Ningbo 5
Redmond 5
San Francisco 5
San Mateo 5
Totale 4.874
Nome #
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 275
c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in Chronic Myelogenous Leukemia CD34+ hematopoietic progenitor cells 263
Higher number of known pancreatic cancer mutations highlighted by whole-transcripto- me and whole-exome sequencing predicts cli- nical outcome in early stage patients 257
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 239
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 231
CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS 226
Simulating tumor microenvironment: changes in protein expression in an in vitro co-culture system. 226
Chondrogenic differentiation of human adipose mesenchimal stem cells: Influence of a biomimetic gelatin genipin crosslinked porous scaffold 225
TERC and c-MYC COPY number gain in intraductal papillary mucinous neoplasms (IPMNs): promising biomarkers of progression to malignancy 220
Cell adhesion and proliferation on gelatin-ascorbic acid scaffold 217
Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model. 214
Gelatin crosslinked with dehydroascorbic acid as a novel scaffold for tissue regeneration with simultaneous antitumor activity. 208
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia. 204
Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression 203
TERC AND MYC COPY NUMBER GAIN AS POWERFUL GENETIC MARKERS FOR INTRADUCTAL PAPILLARY NEOPLASMS OF THE PANCREAS 198
De-Regulation of Extracellular Matrix Proteins in Human Fibroblasts after Long-term and Low Concentrations of HEMA Exposition 195
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 194
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 191
Matricellular protein expression as a new parameter to test in vitro cytotoxicity of a 3D biomimetic material 191
Retroperitoneal lymphangioma: A report of 2 cases and a review of the literature regarding the differential diagnoses of retroperitoneal cystic masses 191
Matricellular Protein Expression and Cell Ultrastructure as Parameters to Test In Vitro Cytotoxicity of a Biomimetic Scaffold 185
State of the art biological therapies in pancreatic cancer 182
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 177
A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM) 176
Novel PLA microspheres with hydrophilic and bioadhesive surfaces for the controlled delivery of fenretinide 175
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients. 174
GAS1 AND KIF27 GENES ARE STRONGLY UP-REGULATED BIOMARKERS OF HEDGEHOG INHIBITION (PF-04449913) ON LEUKEMIA STEM CELLS IN PHASE I ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOID LEUKEMIA TREATED PATIENTS 172
Cell adhesion and proliferation on gelatin-ascorbic acid scaffold 169
High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53 169
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 164
Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients 164
In vitro osteogenic and odontogenic differentiation of human dental pulp stem cells seeded on carboxymethyl cellulose-hydroxyapatite hybrid hydrogel 160
Osteochondral tissue engineering strategies: the role of stem cell source 157
Frontline Treatment of Philadelphia Positive Chronic Myeloid Leukemia with Sequential Administration of Nilotinib 400 Mg Twice Daily and Imatinib 400 Mg Once Daily: a Phase 2 Multicentric Study 146
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients 145
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients 144
IKZF1 (IKAROS) DELETIONS IN BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ARE ASSOCIATED WITH AN IMPAIRED B-CELL DIFFERENTIATION AND POOR OUTCOME 142
Overexpression of FBP1 is Associated to High Sokal Risk in Chronic Myeloid Leukemia Patients. 131
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients 130
NILOTINIB 400 MG BID IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: BEYOND 4 YEARS RESULTS REMAIN STABLE - THE GIMEMA CML WP TRIAL CML0307 117
Proteasome inhibitors: Bortezomib in multiple myeloma 94
The road to cure in multiple myeloma: Incorporation of novel agents into autologous stem cell transplantation 65
Totale 7.706
Categoria #
all - tutte 20.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022777 0 34 28 58 75 69 9 37 37 140 130 160
2022/20231.073 91 178 48 147 69 77 27 60 178 28 77 93
2023/2024386 20 56 25 37 39 120 21 19 8 10 10 21
2024/2025923 42 120 68 77 157 58 57 50 8 94 35 157
2025/20262.190 163 137 209 111 304 120 273 55 501 187 63 67
2026/2027146 88 58 0 0 0 0 0 0 0 0 0 0
Totale 7.706